Prescription Required
Inclusive of all taxes
In Head and neck cancer Head and neck cancer includes cancer of the mouth, nose, sinuses or throat. Erbitux 5mg/ml Solution for Infusion kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated. In Cancer of colon and rectum Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Erbitux 5mg/ml Solution for Infusion treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine, but has some bothersome side effects. Consult your doctor if you have any concerns.
It is not known whether it is safe to consume alcohol with Erbitux 5mg/ml Solution for Infusion. Please consult your doctor.
Erbitux 5mg/ml Solution for Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Erbitux 5mg/ml Solution for Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Erbitux 5mg/ml Solution for Infusion may cause side effects which could affect your ability to drive.
Erbitux 5mg/ml Solution for Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Erbitux 5mg/ml Solution for Infusion may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Erbitux 5mg/ml Solution for Infusion in patients with liver disease. Please consult your doctor.
If you miss a dose of Erbitux 5mg/ml Solution for Infusion, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More